A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults
Status:
COMPLETED
Trial end date:
2025-10-02
Target enrollment:
Participant gender:
Summary
A Phase 1 clinical trial to evaluate the pharmacokinetics, relative bioavailability, safety and tolerability of DHE inhalation powder delivered by dry powder inhaler, DHE IV, and DHE nasal spray.